Assertio to Participate in the 2023 SVB Securities Global Biopharma Conference

Rhea-AI Summary

Assertio Holdings, Inc. (Nasdaq: ASRT), a specialty pharmaceutical company, announced that CEO Dan Peisert and CFO Paul Schwichtenberg will conduct investor meetings on February 15, 2023, during the SVB Securities Global Biopharma Conference, which will be held virtually.

Investors can schedule one-on-one meetings by contacting their SVB Securities representative or reaching out to Matt Kreps in Investor Relations at Assertio. The company offers a wide range of branded prescription products, focusing on neurology, hospital, and pain and inflammation sectors, and has expanded through licensing, mergers, and acquisitions.

LAKE FOREST, Ill., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that Dan Peisert, CEO, and Paul Schwichtenberg, CFO, will host investor meetings February 15, 2023 as part of the SVB Securities Global Biopharma Conference, taking place virtually.

For more information about scheduling a one-on-one meeting with management, please contact your SVB Securities representative or Matt Kreps, Investor Relations for Assertio Holdings, at mkreps@darrowir.com.

About Assertio

Assertio Holdings, Inc. is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through business development including licensing, mergers, and acquisitions. For more information regarding Assertio Holdings, go to: https://www.assertiotx.com/.

Investor Contact:
Matt Kreps
Managing Director
Darrow Associates
Austin, TX
M: 214-597-8200
mkreps@darrowir.com

FAQ

What date will Assertio Holdings host investor meetings?

Assertio Holdings will host investor meetings on February 15, 2023.

Who are the key executives participating in the investor meetings?

The key executives participating are CEO Dan Peisert and CFO Paul Schwichtenberg.

How can investors schedule a meeting with Assertio's management?

Investors can schedule a one-on-one meeting by contacting their SVB Securities representative or Matt Kreps in Investor Relations.

What conference is Assertio Holdings participating in?

Assertio Holdings is participating in the SVB Securities Global Biopharma Conference.

What is the main focus of Assertio Holdings' pharmaceutical products?

Assertio Holdings focuses on neurology, hospital, and pain and inflammation pharmaceutical products.